INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2016
Net Assets |
£202m |
Net Assets per share |
532p |
Share price |
458p |
Total value of unquoted investments |
£24m |
Total number of portfolio companies |
86 |
Top Ten Holdings
Company Name |
% NAV |
Biogen |
7.4 |
Celgene |
6.7 |
Genmab |
6.0 |
Regeneron |
5.0 |
Amgen |
4.4 |
Alexion |
4.4 |
Vertex |
3.5 |
Biomarin |
3.2 |
Actelion |
3.1 |
Intercept |
2.9 |
|
----------- |
Total |
46.6 |
Geographical Allocation |
% NAV |
US & Canada |
77 |
Europe & UK |
23 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
89 |
Unquoted |
11 |
|
----------- |
Total |
100 |
NAV % Market Cap |
% NAV |
Large Cap >USD10BN |
68 |
Small Cap <USD1BN |
26 |
Mid Cap =USD1-10BN |
6 |
|
----------- |
Total |
100 |
NAV % by Therapeutic Areas |
% NAV |
Oncology |
38 |
Orphan |
20 |
CNS |
10 |
Other |
10 |
Inflammation |
9 |
Ophthalmology |
8 |
Medtech |
5 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 JULY 2016